Proteintech acquires nanoantibodies giant

, October 15, 2020, Proteintech Group, a well-known antibody manufacturer, officially announced its wholly-owned acquisition of ChromeTek, a German company. The latter is a well-known manufacturer of nanoantibodies (also known as alpaca monomeal antibodies) dedicated to the development and commercialization of nanoantibodies technology, with a number of the world's leading nanoantibodies technology.
's acquisition expands Proteintech's next-generation antibody tools, further cementing Proteintech's leadership in antibodies, while also better addressing the industry's growing opportunities and challenges in single-cell analysis, ultra-resolution imaging, and multi-analysis, accelerating the implementation of Proteintech's Human Antibody Group Program.
At the same time, the acquisition also means that research users and industrial partners in China and else parts of the country can quickly access ChromeTek's nanoantibodies throughRoteintech's strong sales network, which is a positive driver for the entire biopharmaceutical manufacturing industry and the scientific research sector.
Marion Jung, CEO of ChromeTek, said: "Our next-generation antibody tool, based on nanoantibodies, perfectly complements Proteintech's antibody group program for human proteomics." "Working with a company that has our shared values in repeatability and quality is exciting and brings more benefits to scientific research and other things."
, chief executive of Proteintech, said: "This new partnership will bring considerable value to the market. With the development of global manufacturing systems on three continents, we will not only provide better services to the research market, but will also have a profound impact on translational science and therapeutic applications. Founded2002, Proteintech is a well-known manufacturer of antibodies, proteins and ELISA kits. As an international first-class antibody brand, Proteintech has a complete portfolio of proprietary antibody production products, basically covering the human genome target! Its products have been cited more than 74,000 times by SCI literature, covering all fields of life sciences and medical research. Proteintech also produces human expression, bioactive, cGMP-grade cytokines, growth factors and other proteins that can provide raw materials for clinical diagnosis. Proteintech's production quality management system is ISO13485 and ISO9001-2015 certified. For more information, please visit Chinese Proteintech Website:Founded in 2008, ChromoTek is a pioneer in the development and commercialization of innovative reagents for nanoantibodies in camel animals. In contrast to conventional antibodies, nanoantibodies contain only one polypeptide chain and are the smallest known functional antigen binding fragments. ChromoTek has unique experience and leadership in the development of nanoantibodies with high affinity, specificity and applications for special applications.
GFP-Trap® technology developed by ChromeTek, which combines GFP nanoantibodies with monoplate matrix substrates (agar sugar beads, magnetic beads, and porous plate substrates), has become the gold standard for GFP fusion protein immuno-precipitation or protein interaction experiments; Even, nanoscale antigen surface label displacement that pinpoints targets in ultra-resolution microscopes and output high-quality imaging results, Chromobodies® technology fuses nanoantibodies with fluorescent proteins into commercialized prosurfics, and this innovative fluorescent nano probe enables real-time analysis and visualization of the structure, function, distribution and dynamic processes of endogenic proteins in living cells... These nanoantibodies-based tools can be used in biomedical research in specialized areas where other types of antibodies are not suitable, with unparalleled advantages in the areas of single-cell analysis, ultra-resolution imaging and multi-analysis.
addition, ChromoTek is a trusted service provider for customized nanoantibodies in the pharmaceutical industry and has shown great potential for antibody drugs. For more information, please visit ChromeTek's website.